CUI KUNYUAN has a total of 13 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2004. It filed its patents most often in WIPO (World Intellectual Property Organization), China and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are ADVANCED CANCER THERAPEUTICS LLC, LORUS THERAPEUTICS INC and ABIC LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | China | 3 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | United States | 2 | |
#5 | Australia | 1 | |
#6 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Micro-structure and nano-technology |
# | Name | Total Patents |
---|---|---|
#1 | Cui Kunyuan | 13 |
#2 | Liang Dong | 9 |
#3 | Sweedler David | 4 |
#4 | Quay Steven C | 2 |
#5 | Dattilo James W | 1 |
#6 | Dutzar Benjamin H | 1 |
Publication | Filing date | Title |
---|---|---|
CN107929273A | Liver target medicine | |
US2013156851A1 | Lipomacrocycles and uses thereof | |
US2012289584A1 | Compositions comprising cationic amphiphiles and colipids for delivering therapeutic molecules | |
WO2004098647A2 | Claudins’ underexpression as markers of tumor metastasis |